Congenital pulmonary lymphangiectasia in a newborn: a response to autologous blood therapy.
Congenital pulmonary lymphangiectasia is a rare condition that may present antenatally with pleural effusions and hydrops, and the prognosis is reported to be very poor. Treatments for lymphangiectasia have included corticosteroids for patients with primary inflammatory conditions, dietary modifications, surgical resection for isolated lesions, octreotide, antiplasmin therapy and fibrin glue pleurodesis. However, there is no experience with pleurodesis by autologous blood therapy in the literature. We present a newborn with primary pulmonary lymphangiectasis who developed progressively profuse chylous pleural effusions after enteral full feeding from the 8th day of life and improved with pleurodesis by autologous blood therapy.
Akcakus
Mustafa
M
Division of Neonatology, Department of Paediatrics, School of Medicine, Erciyes University, Kayseri, Turkey.
Koklu
Esad
E
Bilgin
Mehmet
M
Kurtoglu
Selim
S
Altunay
Levent
L
Canpolat
Mehmet
M
Budak
Nurten
N
D001804:Blood Transfusion, Autologous; D006801:Humans; D015160:Hydrops Fetalis / Q000209:etiology / Q000517:prevention & control; D007231:Infant, Newborn; D008171:Lung Diseases / Q000150:complications / Q000628:therapy*; D008200:Lymphangiectasis / Q000150:complications / Q000628:therapy*; D008297:Male; D009634:Noonan Syndrome / Q000235:genetics; D035781:Siblings; D016896:Treatment Outcome